السبت 6 جمادى الأولى 1448هـ
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
تحقق من أن الموقع يستخدم بروتوكول HTTPS
مسجل لدى هيئة الحكومة الرقمية برقم :
| عنوان الدراسة | داعم الدراسة | حالة الدراسة | دواء الدراسة | مرحلة الدراسة | رقم بروتوكول الدراسة | موقع الدراسة |
|---|---|---|---|---|---|---|
| Prospective multi-country, real-world, multi-arm study of treatment PErsistence with RISankizumab in Psoriatic Arthritis | Abbvie/ Ray | Ongoing | Risankizumab | 4 | P24-390 | King Fahad Medical City (Riyadh), King Abdulaziz University Hospital (Jeddah) |
| A Phase 3b, Multicenter, Multi-Country, Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of Orforglipron in Adult Participants with Type 2 Diabetes Who Observe Ramadan Fasting (ACHIEVE-RAM) | Eli Lilly / IQVIA | Ongoing | Orforglipron | 3 | J2A-MC-GZPV | King Saud University Medical City (Riyadh), King Fahad Specialist Hospital (Dammam), Imam Abdulrahman Bin Faisal University (Dammam), King Abdulaziz University Hospital (Jeddah), King Fahad Armed Forces Hospital (Jeddah), King Abdulaziz Medical City NG (Al Ahsa ), Fakeeh Medical Center (Jeddah), King Fahad Medical City (Riyadh) |
| PROLONG Study: Non-Interventional, Observational, Retrospective and Prospective, Single-Arm Study to Assess the Effectiveness of Olaparib and Abiraterone Combination as First Line Therapy in NHA pre-exposed mCRPC patients in the GCC region | PI Initiated | Ongoing | Olaparib and Abiraterone | 4 | D0817R0013 | Security Forces Hospital (Riyadh) |
| Prospective observational study on real-world use of baricitinib for the treatment of adult patients with severe alopecia areata in Saudi Arabia | Eli Lilly Saudi Arabia Ltd./ IQIVIA | Ongoing | Baricitinib | 4 | 2024-14042 | King Fahad Medical City (Riyadh) |
| Spinal Muscular Atrophy Center-based REAL World Retrospective Medical Chart Review of Patient Treated with Onasemnogene Abeparvovec (Zolgensma®) in Saudi Arabia | Novartis/ Ray | Ongoing | Onasemnogene Abeparvovec | 4 | COAV101A1S | King Fahad Specialist Hospital (Dammam) |
| Comparison Between Botox Injections and Trigger Point Injections Efficacy for The Management of Myofascial Pain Syndrome | PI Initiated | Ongoing | Botulinum toxin type A / Lidocaine hydrochloride | 3 | E-24-9413 | King Saud University Dental Center (Riyadh) |
| A Phase 1, Single Center, Randomized, Dose Finding Study, to Evaluate the Safety, Tolerability, and Immunogenicity of a Prophylactic COVID-19 pDNA Vaccine After Multiple Ascending Doses in Healthy Adults | Imam Abdulrahman Bin Faisal University (Dammam) | Ongoing | S.opt.FL pDNA IAUAC | 1 | IAU-1-001-2021 | King Abdulaziz Medical City NG (Riyadh) |
| A Global, Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult and Adolescent Participants with Autoimmune Encephalitis | Argenex/ IQIVIA | Ongoing | Efgartigimod | 2 | ARGX-113-22-AIE-2001 | King Saud University Medical City (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), Imam Abdulrahman Bin Faisal University (Dammam) |
| A Phase 3 Study to Investigate Velzatinib Compared with Imatinib in Adult Participants with Previously Untreated Metastatic And/Or Unresectable Gastrointestinal Stromal Tumors (GIST) And/Or Unresectable Gastrointestinal Stromal Tumors (GIST) | GlaxoSmithKline Research & Development Limited/ Balsam CR | Ongoing | Velzatinib | 3 | 306293 | King Fahad Specialist Hospital (Dammam) |
| The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients with Moderate-to-Severe Atopic Dermatitis in Gulf Countries: DERMIND-AD | Sanofi | Ongoing | Dupilumab | 4 | OBS18647 | Fakeeh Medical Center (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Abdulaziz University Hospital (Jeddah), Specialized Medical Center (Riyadh) |
تاريخ آخر تحديث: 06/10/2026 بتمام الساعة 08:14 صباحا بتوقيت المملكة العربية السعودية
لم يتم تقديم أي تقييمات لهذه الصفحة بعد.
التعليقات والاقتراحات
لأي استفسارات أو ملاحظات حول الخدمات الحكومية، يرجى تعبئة المعلومات المطلوبة.